WI
LGND icon

WrapManager Inc’s Ligand Pharmaceuticals LGND Stock Holding History

WrapManager Inc’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,570
Closed -$346K – 296
2020
Q4 		$346K Buy
5,570
+1,179
+27% +$67.2K 0.1% 186
2020
Q3 		$261K Buy
+4,391
New +$300K 0.09% 198

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

WrapManager Inc's LGND Position: Q1 2021 in Review

WrapManager Inc sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 5,570 shares — an estimated $346K sold.

WrapManager Inc first reported a position in LGND in Q3 2020 and held it in 2 quarters. The position peaked at $346K in Q4 2020. 228 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • WrapManager Inc reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • WrapManager Inc sold 5,570 Ligand Pharmaceuticals shares in Q1 2021, an estimated $346K.
  • WrapManager Inc first reported a position in Ligand Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • WrapManager Inc's Ligand Pharmaceuticals position peaked at $346K in Q4 2020.
  • 228 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on WrapManager Inc's 13F filing for Q1 2021, filed 10 May 2021.